This presentation describes the background of the cornea and the corneal diseases in general, also it describes in detailed manner how to manage the corneal ulcer with its different causes
The tear film is a complex mixture of substances secreted from multiple sources on the ocular surface, including the lacrimal gland, the accessory lacrimal glands, the meibomian glands, and the goblet cells.
This presentation describes the background of the cornea and the corneal diseases in general, also it describes in detailed manner how to manage the corneal ulcer with its different causes
The tear film is a complex mixture of substances secreted from multiple sources on the ocular surface, including the lacrimal gland, the accessory lacrimal glands, the meibomian glands, and the goblet cells.
LIMBUS… • The limbus forms the border between the transparent cornea and opaque sclera, contains the pathways of aqueous humour outflow, and is the site of surgical incisions for cataract and glaucoma
2. Anatomical Limbus: Circumcorneal transitional zone of the conjunctivocorneal & corneoscleral junction Conjunctivo-corneal junction: • Bulbar conjunctiva is firmly adherent to underlying structures • Substantia propria of the conjunctiva stops here but its epithelium continues with that of the cornea. Sclero-corneal junction: • Transparent corneal lamellae become continuous • With the oblique, circular and opaque fibres of sclera
3. CONTINUE…. • In the area near limbus, the conjunctiva, tenon’s capsule & the episcleral tissue are fused into a dense tissue which is strongly adherent to corneo scleral junction.It is preferred site for obtaining a firm hold of the eyeball during ocular surgery. • The limbus is a common site for the occurrence of corneal epithelial neoplasm. • The Limbus contains radially oriented fibrovascular ridge known as the palisades of Vogt that may harbour a stem cell population. The palisades of Vogt are more common in the superior and inferior quadrants around the eye
Each eyelid contains a fibrous plate, called a tarsus, that gives it structure and shape; muscles, which move the eyelids; and meibomian (or tarsal) glands, which secrete lubricating fluids. The lids are covered with skin, lined with mucous membrane, and bordered with a fringe of hairs, the eyelashes.
LIMBUS… • The limbus forms the border between the transparent cornea and opaque sclera, contains the pathways of aqueous humour outflow, and is the site of surgical incisions for cataract and glaucoma
2. Anatomical Limbus: Circumcorneal transitional zone of the conjunctivocorneal & corneoscleral junction Conjunctivo-corneal junction: • Bulbar conjunctiva is firmly adherent to underlying structures • Substantia propria of the conjunctiva stops here but its epithelium continues with that of the cornea. Sclero-corneal junction: • Transparent corneal lamellae become continuous • With the oblique, circular and opaque fibres of sclera
3. CONTINUE…. • In the area near limbus, the conjunctiva, tenon’s capsule & the episcleral tissue are fused into a dense tissue which is strongly adherent to corneo scleral junction.It is preferred site for obtaining a firm hold of the eyeball during ocular surgery. • The limbus is a common site for the occurrence of corneal epithelial neoplasm. • The Limbus contains radially oriented fibrovascular ridge known as the palisades of Vogt that may harbour a stem cell population. The palisades of Vogt are more common in the superior and inferior quadrants around the eye
Each eyelid contains a fibrous plate, called a tarsus, that gives it structure and shape; muscles, which move the eyelids; and meibomian (or tarsal) glands, which secrete lubricating fluids. The lids are covered with skin, lined with mucous membrane, and bordered with a fringe of hairs, the eyelashes.
to download this presentation from this link
https://mohmmed-ink.blogspot.com/2020/11/conjunctival-diseases-overview.html
over view for the conjunctival diseases. clinical presentation treatment .
Allergic conjunctivitis is inflammation of the conjunctiva (the membrane covering the white part of the eye) due to allergy.Although allergens differ among patients, the most common cause is hay fever. Symptoms consist of redness (mainly due to vasodilation of the peripheral small blood vessels), edema (swelling) of the conjunctiva, itching, and increased lacrimation (production of tears). If this is combined with rhinitis, the condition is termed allergic rhinoconjunctivitis.
The symptoms are due to release of histamine and other active substances by mast cells, which stimulate dilation of blood vessels, irritate nerve endings, and increase secretion of tears.
Treatment of allergic conjunctivitis is by avoiding the allergen (e.g., avoiding grass in bloom during "hay fever season") and treatment with antihistamines, either topical (in the form of eye drops), or systemic (in the form of tablets). Antihistamines, medications that stabilize mast cells, and nonsteroidal anti-inflammatory drugs (NSAIDs) are generally safe and usually effective.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
2. Introduction:
It is a Translucent mucous membrane which
lines the posterior surface of the eyelids and
anterior aspect of the eyeball
It stretches from the lid margin to the limbus
3. Parts of Conjunctiva
Palpebral Conjunctiva
1. Marginal
2. Tarsal
3. Orbital
Bulbar conjunctiva
1. Scleral
2. Limbal
Conjunctival fornix
1. Superior
2. Inferior
3. Lateral
4. Medial
4. Palpebral Conjunctival
Marginal conjunctiva
• It extends from the lid margin to about 2mm on the
back of the lid upto a shallow groove – Subtarsal
sulcus .
• The sulcus is the commonest site for lodgement of a
conjunctival foreign body .
5. Tarsal Conjunctiva
• Thin, transparent, highly vascular
• It is firmly adherent to the whole tarsal
plate in the upper lid and in lower lid only
half width of the tarsus.
Orbital part
• It lies loose between the tarsal plate and
fornix
6. Bulbar Conjunctiva
Limbal
• A 3mm ridge of the bulbar conjunctiva around he
cornea is called as limbal conjunctiva
Scleral
• Covers the eyeball above the anterior sclera
• Thin , transparent and loosely attached to the
underlying sclera
7. Conjunctival Fornix
It joins the bulbar conjunctiva with the palpebral conjunctiva
It is broken only at the medial side by the caruncle and plica
semilunaris
8. Plica Semilunaris
Pinkish crescentic fold of conjunctiva , present in the medial
canthus
Its lateral free border is concave
Caruncle
Small, ovoid, pinkish mass, situated in the inner canthus ,
just medial to the plica semilunaris
Piece of modified skin and consists of sweat glands ,
sebaceous glands and hair follicles
9. Structure Of Conjunctiva
Conjunctiva consists of 3 layers
1. Epithelium
2. Adenoid layer
3. Fibrous layer
10. Epithelium
Marginal part : 5 layers of stratified squamous
- superficial layer –squamous cell
-intermediate 3 layers – polyhedral cells
-deepest layer –goblet cells
Tarsal part : 2 layers
- superficial is cylindrical cells
- deeper is flat cells
• Lower tarsal conjunctiva is made up of 3-4 layers of cells like the cubical,
polygonal , elongated ,wedge shaped and cone shaped cells
12. Adenoid layer
Lymphoid layer
It is not present since birth but develops after 3-4 months of life .
For this reason, conjunctival inflammation in an infant does not produce
follicular reactions.
13. Fibrous layer
Meshwork of collagenous and elastic fibers
Thicker than adenoid layer except in the Tarsal conjunctiva
Consists of nerves and vessels of conjunctiva
14. Conjunctival glands
It consists of two types of glands :
Mucin secretory glands :
1. Goblet cells
2. Crypts of Henle
3. Glands of Manz
Accessory lacrimal glands :
1. Glands of Krause
2. Glands of Wolfring
15. Blood Supply
Arteries :
- Derived from 3 sources
1. Peripheral arterial arcade of eyelids
2. Marginal arterial arcade of eyelids
3. Anterior ciliary arteries
Palpebral and fornix part : Peripheral and Marginal arterial arcade of
eyelid
Bulbar part : Anterior and posterior conjunctival arteries
16. Nerve Supply
Circumcorneal zone : Branches from long ciliary nerves
Rest : by branches from
1. Lacrimal nerve
2. Infratrochlear nerve
3. Supratrochlear nerve
4. Supraorbital nerve
5. Frontal nerve
17. Lymphatic Drainage
Lymphatics of conjunctiva are arranged in 2 layers
- superficial
- deep
Lymphatics from the lateral side drain into preauricular lymph nodes
Lymphatics from the medial side drain into the submandibular lymph
nodes.
18. Diseases Of Conjunctiva
1. Degenerative conditions
2. Inflammatory conditions
3. Symptomatic conditions
4. Cysts and Tumours
20. Pinguecula
Extremely common degenerative change
Yellowish white path on bulbar conjunctiva near the limbus ,
nasal or temporal .
21. Etiology
Age related change
Strong sunlight exposure
Dusty , windy and smoky working environment
?Considered as a precursor of pterygium
22. Symptoms :
Usually asymptomatic
Possible mild foreign body sensation and redness when inflamed
Occasional cosmetic concern
23. Signs :
Area of conjunctival thickening adjoining the limbus
In the palpebral aperture, usually at 3 & 9 o’clock positions
More common nasally
Usually bilateral
Elevated and less transparent than normal conjunctiva
White to yellow colour, fat like appearance
May become inflamed causing mild ocular irritation
Decreased TBUT
24. Management by Optometrist
Non pharmacological
• Reassure patient about benign nature of the lesion (no threat to health or
sight)
• Advise on UV protection to minimise risk of inflammation
-brimmed hat, sunglasses in wrap-around style for side protection
• Cold compresses when inflamed
Pharmacological
• Ocular lubricants for symptomatic relief
25. Pterygium
Pterygium is a wing shaped fold of conjunctiva encroaching upon the
cornea from either side within the interpalpebral fissure.
Etiology ;
1. More common in people living in hot climates .
2. Exposure to sun
3. Dry heat
4. High wind
5. Abundance of dust
26. Signs
Usually bilateral; often asymmetrical.
More common nasally
Starts with scarring, thickening and distortion of the bulbar conjunctiva
Slow insidious growth on to cornea (or may become stable)
Destroys Bowman’s membrane and superficial stroma lamellae
Epithelial iron deposit (Stocker’s line) ahead of advancing pterygium
Relatively rich surface vascularisation
Flattening of cornea in horizontal meridian
27. Symptoms
Mild irritation (redness, dryness, foreign body sensation)
May be exacerbated by incidents of acute inflammation
Cosmetic concern
28. Types of pterygium
1. Progressive
Thick , fleshy , vascular
Few infiltrates in the cornea , in front of the head of the pterygium
(Fuch’s spot)
1. Regressive
Thin , atrophic , attenuated , very little vascularity
Sometimes deposition of iron may be present
29. Treatment
Surgical excision is the only satisfactory treatment .
Indications :
1. Cosmetic disfigurement
2. Visual impairment
3. Continued progression
4. Diplopia due to interference in ocular movement
30. Management by Optometrist
Non pharmacological
• Advise on UV protection:
-brimmed hat, tinted lenses, wrap-around style for side protection
-reduces risk of progression and of becoming inflamed and irritated
• Measure and draw diagram (photo document if possible)
• Cold compress when inflamed
Pharmacological
Ocular lubricants for symptomatic relief
31. Concretions
Concretions are formed due to accumulation of inspisated
mucus and dead epithelial cell debris into the conjunctival
depressions called loops of henle .
32. Symptoms :
1. Usually none
2. May erode through the epithelium
3. foreign body sensation
Signs :
1. Small white/yellow-white bodies with distinct edges in tarsal conjunctiva
2. Single or multiple Usually <1mm dia, sometimes up to 3mm
3. Usually low profile but may be raised if large.
33. Management by optometrist
Non pharmacological
• Treatment rarely required
• Artificial tears and lubricating ointments
• Eroded concretions leading to irritation can be removed at the slit lamp
-topical anaesthetic
- with sterile hypodermic needle
Pharmacological
• No specific drug treatment available
34. Amyloid Degeneration Of Conjunctiva
Rare
Occurs in 2 forms :
1. Primary conjunctival amyloid
2. Secondary conjunctival amyloid
35. Clinical Features :
1. Deposition of yellowish , well demarcated, irregular amyloid
material in the conjunctiva
2. Subconjunctival haemorrhage may be associated with amyloid
deposition in blood vessels
Treatment :
1. Lubricating drops for mild symptoms .
2. Excision can be performed with marked irritation due to raised
lesions .
36. Symptomology
• Non-Specific
Lacrimation
Irritation
Stinging
Photophobia
Burning
Redness
• Specific
Pain and FB sensation in Corneal Involvement
Itching in allergic, Blepharitis and dry eyes
37. Conjunctival Signs
Type of Discharge
Type of conjunctival reaction
Presence of membrane/ Pseudo-membrane
Lymphadenopathy
Pigmentations
38. Discharge :
It is exudation from abnormally dilated blood vessels filtered
through conjunctival epithelium .
Types of discharge :
1. Watery Discharge – Viral infection
2. Mucinous Discharge – keratoconjunctivitis sicca
3. Purulent Discharge – severe bacterial infection
4. Mucopurulent Discharge – mild bacterial infection
40. Papillae
It is response of conjunctiva to inflammation
It consists of small capillary network surrounded by fibrous
network
hyperplasia of epithelium
usually more discrete and more red than follicles
side walls of papillae appear perpendicular to tarsal plate
41. Follicles
Follicles appear as multiple discrete slightly elevated lesions
They may be 0.5 to 5 mm in size depending upon severity and duration
Follicles present lymphocytic response
Commonly seen in lower palpebral conjunctiva
Acute Follicular Response- <4 weeks
Chronic Follicular Response- >4 weeks
hyperplasia of lymphoid tissue
generally seen in viral conditions
smooth, pale, pink-to-yellow, elevated lesions
surrounded by displaced vessels
42. Chemosis
It is seen when conjunctiva is inflamed and hyperemic due to transdation
of fibrin and protein rich fluid through damaged blood vessels .
Due to laxity of bulbar conjunctiva the fluid commonly gets collected there
Ballooning of conjunctiva occurs when fluid is in large quantity it is labelled
as chemosis
44. Membranous
Acute inflammation of the conjunctiva
Lids are hardened
semisolid exudates: result in necrosis of conjunctiva and cornea
difficult to peel off
associated with bleeding from the under surface
45. Lymphadenopathy-Swelling of Lymph
nodes
Pre auricular and sub mandibular.
1. Viral infection.
2. Chlamydial infection.
3. Severe bacterial infections. (Gonococcal)
4. Parinaud oculo-glandular syndrome.
46. Bacterial Conjunctivitis
• Predisposing factors
contamination of the conjunctival surface
superficial trauma
contact lens wear
secondary to viral conjunctivitis
recent cold, upper respiratory tract infection or sinusitis
Diabetes
Steroids
Blepharitis
47. Symptoms
Acute onset of:
• redness
• discomfort, usually described as burning
• discharge
• Usually bilateral – one eye may be affected before the other (by one or two
days)
48. Signs
Lid crusting
Purulent or mucopurulent discharge
Conjunctival hyperaemia – maximal in fornices
Tarsal conjunctiva may show mild papillary reaction
49. Management by optometrist
• Non pharmacological
Often resolves in 5-7 days without treatment
Bathe/clean the eyelids with lint or cotton wool dipped in sterile saline or
boiled (cooled) water to remove crusting
Advise patient that condition is contagious (do not share towels, etc.)
• Pharmacological
Treatment with topical antibiotic may improve short-term outcome and
render patient less infectious to others
50. CL-associated Papillary Conjunctivitis (CLAPC),
Giant Papillary Conjunctivitis (GPC)
• Predisposing factors
Common in soft compared to rigid lenses
reported in silicone hydrogel, as well as hydrogel, lens wearers
Lens deposits
Thick or poorly designed or manufactured lens edges
Meibomian gland dysfunction
51. Symptoms
Itching and non-specific irritation
may increase after lens removal Mucus discharge
Increased lens movement
Loss of lens tolerance
Decreasing comfort
Blurred vision
52. Signs
Almost always bilateral
Upper tarsal conjunctiva (lower usually not affected)
papillae
macro papillae (diameter between 0.3 and 1 mm) or giant papillae
(diameter > 1 mm)
hyperaemia
stringy mucus in tear film and on conjunctival surfaces
conjunctival oedema
53. Management by optometrist
• Non pharmacological
Removal of lens deposits
Reduce exposure time
Optimize lens fit, material and wearing regime
o change soft lens material to one with improved deposit resistance
o change to daily disposable soft lenses
54. Acute Allergic Conjunctivitis
• Aetiology
A self-limiting reaction to an allergen (often unidentified) that comes into
contact with the conjunctiva provoking an immediate response
Common in children
Allergens include: grass pollen, animal dander , dust
• Predisposing factors
History of allergic disease; can also occur without such history
55. • Symptoms
Eyelid swelling
Itching
May be unilateral (if a direct contact response)
• Signs
Lid oedema
Conjunctival chemosis
Mild watery or mucoid discharge
56. Management by optometrist
• Non pharmacological
Most cases resolve spontaneously within a few hours
Advise against eye rubbing (causes mechanical mast cell degranulation)
Cool compresses may give relief
If possible identify allergen and advise future avoidance
Advise patient to return/seek further help if symptoms persist
• Pharmacological
Not normally required (although ocular lubricant drops and/or topical anti-
histamines may provide symptomatic relief)
57. Seasonal Allergic Conjunctivitis
• Predisposing factors
Atopic disposition
Personal history of allergic disease (hay fever, asthma, eczema, food or
drug allergy)
Family history of allergic disease
Exposure to allergens
58. Symptoms
Itching
Watering of eye
May be associated with sneezing and watery nasal discharge
symptoms seasonal with climatic variations
59. Signs
Mild to moderate lid oedema
Bulbar and tarsal conjunctiva: chemosis , hyperaemia and diffuse papillary
reaction
60. Management by optometrist
Identify allergens
Advise avoidance of allergens
Cool compresses for symptomatic relief
Advise against eye rubbing
61. Viral Conjunctivitis
• Predisposing factors
Recent cold or other upper respiratory tract infection
Low standards of hygiene
Crowded conditions (schools, camps, clinics)
Eye clinics (transmission by clinicians’ fingers, tonometer , etc.)
62. Symptoms
Acute onset of :
redness
Discomfort
watering
Eyelids may be stuck together in the morning
Often unilateral at first, becoming bilateral
Blurred vision if central cornea involved
63. Signs
Watery discharge
Hyperemia
Follicles
Subconjunctival haemorrhages
Pseudo membranes
Pre-auricular lymphadenopathy which may be tender (not present in every
case)
Corneal involvement in some cases
64. Management by optometrist
• Non pharmacological
Wash hands carefully before and after examination and clean equipment
before next patient
Do not applanate with a re-usable tonometer
• Advise patient:
condition is normally self-limiting, resolving within one to two weeks
condition is highly contagious (do not share towels, etc)
cold compresses may give symptomatic relief
discontinue contact lens wear in acute phase